NINLARO (ixazomib) 

ORAL ADMINISTRATION

Indications for Prior Authorization:

  • Multiple myeloma

All of the following must be met as a condition for coverage:

  • Treatment of multiple myeloma (in combination with lenalidomide and dexamethasone) in patients who have received at least 1 prior therapy

This Medication is Not Approvable for the following condition(s).

  • Any condition not listed above as an approved indication

Dosing:

  • 4 mg once weekly on days 1, 8, and 15 of a 28-day treatment cycle (in combination with lenalidomide and dexamethasone)
  • Continue until disease progression or unacceptably toxicity
Approval:
 
One Year
 

 

Last review date: July 25, 2016

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone